Evidence map›Paper›PMID 29085404›Full record

ArticleAfrican health sciences2017

Hepatitis B virus DNA polymerase gene polymorphism based prediction of genotypes in chronic HBV patients from Western India.

Yashwant G Chavan, Sharad R Pawar, Minal Wani, Amol D Raut, Rabindra N Misra

Open access · diamondAbstract read
In one paragraph

Article in African health sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Genotyping of hepatitis B virus isolates from Lahaul and Spiti district in Himachal Pradesh, India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yashwant G ChavanDr. D Y Patil Biotechnology and Bioinformatics Institute, Tathwade, Pune 411033. Dr. D Y Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018. Maharashtra, India.
Sharad R PawarMedical Genetics, geneOmbio Technologies Private Limited, Baner, Pune 411045. Maharashtra, India.
Minal WaniDr. D Y Patil Biotechnology and Bioinformatics Institute, Tathwade, Pune 411033. Dr. D Y Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018. Maharashtra, India.
Amol D RautMedical Genetics, geneOmbio Technologies Private Limited, Baner, Pune 411045. Maharashtra, India.
Rabindra N MisraDr. D Y Patil Biotechnology and Bioinformatics Institute, Tathwade, Pune 411033. Dr. D Y Patil Vidyapeeth, Sant Tukaram Nagar, Pimpri, Pune 411018. Maharashtra, India.
Dr. D.Y. Patil Vidyapeeth, Pune · INMedical Technologies (Czechia) · CZDr. D. Y. Patil Medical College, Hospital and Research Centre · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatitis B Virus (HBV) infection is one of the major causes of liver cirrhosis, hepatocellular carcinoma and deaths due to the acute or chronic consequences worldwide. HBV is distributed into various genotypes based on nucleic acid sequence variation.

objectivesTo develop a method of HBV genotyping and drug resistance interpretation using partial sequencing of polymerase gene.

methodsThis study was performed on 98 HBV infected patients' serum samples from Western India. A nested PCR protocol was designed for amplification of pol gene from HBV genome and Sanger's sequencing of the gene fragment. Sequences were aligned with HBV reference sequences for phylogenetic analysis and for characterization of genetic diversity. Drug resistance mutations were screened using HBVSeq program from Stanford University.

resultsDistribution of HBV genotypes showed predominance of genotype D, circulating in 76 (77.55%) patients (p < 0.05). Genotypes A and C were less prevalent and were identified in 4 (4.08%) and 18 (18.37%) patients, respectively. Anti-retroviral drug resistance mutations were not detected in any patient.

conclusionA method for determination of HBV genotypes using pol gene sequencing which simultaneously detects major drug resistance mutations has been established. HBV genetic diversity may play an important role in treatment decision.

Indexed as

MutationAdultDNA-Directed DNA PolymeraseDNA, ViralGenetic VariationGenotypeHepatitis B, ChronicHepatitis B virusHumansIndiaMaleMolecular EpidemiologyPhylogenyPolymerase Chain ReactionPolymorphism, GeneticDNA-Directed DNA PolymeraseDNA, ViralgenotypeHepatitis B virusnested PCRsub-genotypesYMDD mutations

Identifiers

PMID29085404
PMCPMC5656201
OpenAlexW2754552920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.